Final - June 15, 2012

AGENDA ITEM PURPOSE PRESIDER / PRESENTER(s)

Wednesday, June 20, 2012 

8:00 AM - Welcome and Introductions Dr. Carol Baker (ACIP Chair)

Dr. Larry Pickering (ACIP Executive Secretary; CDC) 

8:30 AM - Pneumococcal Vaccines 

Introduction Information & Discussion Dr. Nancy Bennett (ACIP, WG Chair)

Impact of PCV13 use in children Dr. Matthew Moore (CDC/NCIRD)

PPSV23 for adults with immunocompromising conditions: background, review 

of data, and GRADE

Ms. Tamara Pilishvili (CDC/NCIRD)

PCV13 for adults with immunocompromising conditions: background, review 

of data, and GRADE

Dr. Kathleen Dooling (CDC/NCIRD)

Cost-effectiveness of PCV13 for adults with immunocompromising conditions Dr. Charles Stoecker (CDC/NCIRD)

Recommendations for PCV13 use among immunocompromised adults Vote Ms. Tamara Pilishvili (CDC/NCIRD)

10:15 AM - Break

10:45 AM - Influenza

Introduction Information & Discussion Dr. Wendy Keitel (ACIP, WG Chair)

Influenza activity/surveillance update Dr. Lyn Finelli (CDC/NCIRD)

Vaccine effectiveness Dr. David Shay (CDC/NCIRD)

Vaccine safety update Dr. Tom Shimabukuro (CDC/NCEZID)

Proposed recommendations Vote & VFC Vote Dr. Lisa Grohskopf (CDC/NCIRD)

12:00 PM - Lunch

1:15 PM - Hepatitis B Protection for Healthcare Personnel (HCP)

Introduction Information & Discussion Dr. Mark Sawyer (ACIP, WG Chair)

Overview of hepatitis B protection among HCP Dr. Sarah Schillie (CDC/NCHHSTP)

Risk of exposure and antibody levels over time Ms. Meredith Reilly (CDC/NCHHSTP)

Hepatitis B protection among HCP: cost-effectiveness considerations Dr. Tom Hoerger (Senior Fellow, RTI International)

Future considerations Dr. Sarah Schillie (CDC/NCHHSTP)

3:15 PM - Break

3:45 PM - Pertussis Vaccines 

Update: ACIP Pertussis Vaccines Work Group Information Dr. Mark Sawyer (ACIP, WG Chair)

Update: pertussis outbreak in Washington State

Dr. Jeffrey Duchin (ACIP; Chief Communicable Disease 

Epidemiology & Immunization Section, Public Health-Seattle 

& King County)

4:10 PM - Meningococcal Vaccines

Update: Meningococcal Vaccines Work Group Information Dr. Cody Meissner (ACIP, WG Chair)

4:25 PM - Development of Evidence-Based Recommendations Using GRADE

Development of ACIP/CDC vaccine recommendations using GRADE Information & Discussion Dr. Jonathan Temte (ACIP)

Strategic Advisory Group of Experts on Immunization (SAGE) approach to 

updating WHO Vaccine Position Papers

Professor David Durrheim, University of Newcastle, 

Australia; SAGE Member

Update on GRADE Dr. Faruque Ahmed (CDC/NCIRD)

5:10 PM - Vaccine Supply Information Dr. Jeanne Santoli (CDC/NCIRD)

5:25 PM - Public Comment

5:40 PM - Adjourn

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

 1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30333

June 20-21, 2012

1
Final - June 15, 2012

AGENDA ITEM PURPOSE PRESIDER / PRESENTER(s)

Thursday, June 21, 2012

8:00 AM - Unfinished Business Dr. Carol Baker (ACIP Chair)

8:15AM - Agency Updates

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH CDC and Ex Officio members

8:30 AM - IOM Vaccine Committee Report 

Identifying and prioritizing new preventive vaccines for development

Information & Discussion

Dr. Guruprasad Madhavan, Dr. Tracy Lieu (IOM Committee 

on Identifying and Prioritizing New Vaccines for 

Development)

9:00 AM - Adult Immunization

Introduction Information & Discussion Ms. Kristen Ehresmann (ACIP, WG Chair)

Non-influenza vaccination rates among US adults Dr. Walter Williams (CDC/NCIRD)

Plans for expanding vaccine coverage tracking for US adults using BRFSS

Dr. Walter Williams (CDC/NCIRD)

Report on first National Adult Immunization Summit Dr. Carolyn Bridges (CDC/NCIRD)

9:30 AM - Human Papillomavirus (HPV) Vaccines

Introduction Information & Discussion Dr. Joseph Bocchini (ACIP, WG Chair)

IIS sentinel site data: uptake of HPV vaccine in the US Dr. Karen Cullen (CDC/NCIRD)

HPV vaccine update Dr. Lauri Markowitz (CDC/NCHHSTP)

10:30 AM - Break

11:00 AM - Anthrax Vaccine Adsorbed (AVA)

Considerations for AVA post-exposure prioritization 

Information

Dr. Nancy Messonnier (CDC/NCIRD)

Dr. Raymond Strikas (CDC/NCIRD)

11:30 AM - Measles, Mumps, Rubella (MMR) Vaccine

Introduction Information & Discussion Dr. Jon Temte (ACIP, WG Chair)

Epidemiology of rubella and congenital rubella syndrome (CRS) in the United 

States

Dr. Huong McLean (CDC/NCIRD)

Post exposure prophylaxis for measles with immune globulin Dr. Mark Papania (CDC/NCIRD)

Review of policy considerations pertaining to MMR vaccine Dr. Huong McLean (CDC/NCIRD)

12:45 PM - Public Comment

1:00 PM - Adjourn

Acronyms

CMS Centers for Medicare and Medicaid Services

DoD Department of Defense

DVA Department of Veterans Affairs

FDA Food and Drug Administration

GRADE Grading of Recommendations Assessment, Development and Evaluation

HRSA Health Resources and Servies Administration

I H S Indian Health Service

IIS Immunization Information Systems (Immunization Registries) 

IOM Institute of Medicine

NCCDPHP National Center for Chronic Disease Prevention and Health Promotion

NCEZID National Center for Emerging and Zoonotic Infectious Diseases

NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

NCIRD National Center for Immunization and Respiratory Diseases

NIH National Institues of Health

NVPO National Vaccine Program Office

PCV13 13-valent Pneumococcal Conjugate Vaccine

PPSV23 23-valent Pneumococcal Polysaccharide Vaccine

SAGE Strategic Advisory Group of Experts (WHO)

TBD To be determined

Tdap Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine

WG Work Group

WHO World Health Organization

2